Latest Investor Confidence News

Astron Limited has responded to an ASX query regarding delayed disclosure of director interest changes, attributing the lapse to administrative oversight and outlining steps to tighten compliance.

Askari Metals has responded to an ASX query regarding an inadvertent breach of Listing Rule 10.11 after issuing securities to a related party without prior shareholder approval during a recent rights issue. The company outlines the circumstances and its planned remedial actions.

ION Video Ltd’s recent General Meeting saw overwhelming shareholder approval for crucial resolutions, including a securities consolidation and advisor options ratification.

Openn Negotiation Limited has reported a return to profitability for the year ended 30 June 2025, posting a total comprehensive profit of $412,860. The company will hold its Annual General Meeting in January 2026, with no dividends proposed.

Global Masters Fund Limited reports steady convertible note activity and a robust loan-to-value ratio of 9.36% for the December 2025 quarter, underscoring its solid financial footing.

Flagship Investments Limited has confirmed stable financial metrics for its convertible notes in the December 2025 quarter, maintaining a conservative loan-to-value ratio and full compliance with regulatory requirements.

MetalsTech Limited has successfully raised approximately $9.4 million through a share placement, alongside a $2 million debt conversion, to fast-track its Sturec Gold Project in Slovakia.

Eastern Metals Limited has responded to ASX concerns over delayed disclosure of director interest changes, attributing the lapse to end-of-year administrative challenges while affirming its compliance framework remains robust.

Osteopore Limited has completed the full subscription of Tranche 1 under its A$20 million convertible notes facility, raising an additional A$250,000 to support ongoing business and future projects.

Whitefield Income Limited has announced fully franked monthly dividends for the first quarter of 2026, alongside a half yearly top-up dividend, delivering a solid yield based on recent share prices.

AdAlta Limited has raised A$1.2 million through a strategic placement to advance its innovative PD1 armored MSLN CAR-T therapy for solid cancers, reinforcing its unique 'East to West' cellular immunotherapy approach.

Findi Limited has resumed trading on the ASX following a key announcement about a strategic investment secured by its Indian subsidiary, signaling renewed investor interest.